Search - tctmd.com

Displaying 261 - 280 of 1588

Sort: Relevancy | Date

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

Presentation TCT 2023

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

October 25, 2023

Presentation TCT 2023

How I Have Started to Use DCB’s: A Look into the Future

Presenter: Antonio Colombo

October 25, 2023

Presentation TCT 2023

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

Presenter: Daniel Burkhoff

October 25, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2023

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

Presenter: Ajay Kirtane

October 25, 2023

Presentation TCT 2023

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Presenter: Rayyan Hemetsberger

October 25, 2023

Presentation TCT 2023

Treatment of Aortic Regurgitation Using Dedicated TAVR Systems: Early European Experiences and Description of the Align AR Trial

Presenter: Stephan Baldus

October 25, 2023

Presentation TCT 2023

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

Exemplary Cases From the LIFE-BTK Trial

Presenter: Lawrence Garcia

October 25, 2023

Presentation TCT 2023

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Presenter: Ajay Kirtane

October 25, 2023

Presentation TCT 2023

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

Presenter: Michael Bloch

October 25, 2023

Presentation TCT 2023

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

Presenter: Usman Naseer

October 25, 2023

Presentation TCT 2023

Essential Features of the Core Laboratory Protocols: Lessons Worth Learning

Presenter: Raghu Kolluri

October 25, 2023

Advertisement

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

How I Have Started to Use DCB’s: A Look into the Future

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Treatment of Aortic Regurgitation Using Dedicated TAVR Systems: Early European Experiences and Description of the Align AR Trial

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

Exemplary Cases From the LIFE-BTK Trial

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

Essential Features of the Core Laboratory Protocols: Lessons Worth Learning

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content